Cargando…
Natural product drug discovery in the artificial intelligence era
Natural products (NPs) are primarily recognized as privileged structures to interact with protein drug targets. Their unique characteristics and structural diversity continue to marvel scientists for developing NP-inspired medicines, even though the pharmaceutical industry has largely given up. High...
Autores principales: | Saldívar-González, F. I., Aldas-Bulos, V. D., Medina-Franco, J. L., Plisson, F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8827052/ https://www.ncbi.nlm.nih.gov/pubmed/35282622 http://dx.doi.org/10.1039/d1sc04471k |
Ejemplares similares
-
Schistosomiasis Drug Discovery in the Era of Automation and Artificial Intelligence
por: Moreira-Filho, José T., et al.
Publicado: (2021) -
Challenges in natural product-based drug discovery assisted with in silico-based methods
por: Simoben, Conrad V., et al.
Publicado: (2023) -
Latin American databases of natural products: biodiversity and drug discovery against SARS-CoV-2
por: Núñez, Marvin J., et al.
Publicado: (2021) -
Editorial: Computer-aided drug design: Drug discovery, computational modelling, and artificial intelligence
por: Ye, Fei, et al.
Publicado: (2022) -
Use of Artificial Intelligence and Machine Learning for Discovery of Drugs for Neglected Tropical Diseases
por: Winkler, David A.
Publicado: (2021)